Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2015 Q1 - 2017 Q3
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 267 300 271 268 286 271 268 261 258 246 259
20 - 44 3,780 3,635 3,444 3,504 3,744 3,545 3,293 3,463 3,617 3,504 3,138
45 - 64 12,839 12,126 11,459 11,906 12,773 11,994 11,231 11,678 12,584 11,695 10,928
65 - 74 8,450 8,134 7,703 8,113 8,997 8,587 7,977 8,263 8,787 8,507 7,907
75 + 7,585 7,346 6,871 7,120 7,730 7,154 6,667 6,975 7,581 7,260 6,495
Male 19,249 18,377 17,129 18,006 19,556 18,145 16,962 17,794 19,189 18,094 16,707
Female 13,672 13,164 12,619 12,905 13,974 13,406 12,474 12,846 13,638 13,118 12,020
Diabetes 15,044 14,199 13,491 14,610 15,857 14,730 13,699 14,462 15,494 14,407 13,207
Hypertension 9,573 9,152 8,450 8,387 9,303 8,813 8,360 8,712 9,321 8,921 8,203
Glomerulonephritis 2,383 2,423 2,252 2,345 2,521 2,287 2,173 2,201 2,400 2,200 1,947
Cystic kidney 667 694 701 836 922 935 864 836 883 854 828
Other urologic 368 347 334 456 450 452 396 426 444 460 372
Other cause 2,977 2,923 2,903 3,199 3,315 3,284 2,967 3,017 3,090 3,101 2,669
Unknown cause 801 741 635 124 144 112 99 102 115 114 93
Missing cause 1,108 1,062 982 954 1,018 938 878 884 1,080 1,155 1,408
All 32,921 31,541 29,748 30,911 33,530 31,551 29,436 30,640 32,827 31,212 28,727

^ Data as of December 31, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2015 Q1 - 2017 Q3
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
0 - 19 7,627 7,644 7,600 7,606 7,644 7,648 7,636 7,577 7,568 7,537 7,503
20 - 44 105,514 105,938 105,845 105,812 105,995 106,192 105,992 106,006 106,213 106,606 106,331
45 - 64 303,829 306,436 308,156 310,287 312,677 314,839 316,202 317,367 319,233 320,891 321,415
65 - 74 160,406 162,703 165,170 167,571 170,118 172,952 175,056 177,164 178,663 180,959 183,240
75 + 110,331 111,606 113,111 114,415 115,410 116,696 118,048 118,882 119,645 121,082 122,548
Male 396,271 400,529 403,820 407,507 411,640 415,425 418,221 420,814 423,613 427,380 430,112
Female 291,364 293,727 295,992 298,115 300,135 302,834 304,645 306,114 307,644 309,630 310,861
Unknown 72 71 70 69 69 68 68 68 65 65 64
Diabetes 262,311 265,131 267,491 270,358 273,385 276,327 278,335 280,028 281,937 284,297 285,614
Hypertension 175,784 177,845 179,421 180,730 182,402 184,249 185,813 187,196 188,448 190,146 191,420
Glomerulonephritis 111,266 111,934 112,477 112,985 113,520 113,960 114,286 114,551 114,867 115,221 115,324
Cystic kidney 32,536 32,783 33,028 33,452 33,891 34,365 34,761 35,141 35,497 35,851 36,235
Other urologic 11,334 11,384 11,421 11,536 11,592 11,720 11,786 11,886 11,952 12,057 12,089
Other cause 59,313 59,846 60,330 61,164 61,638 62,337 62,664 62,990 63,287 63,889 64,126
Unknown cause 24,688 24,697 24,650 24,087 23,584 23,154 22,716 22,251 21,827 21,439 21,088
Missing cause 10,475 10,707 11,064 11,379 11,832 12,215 12,573 12,953 13,507 14,175 15,141
All 687,707 694,327 699,882 705,691 711,844 718,327 722,934 726,996 731,322 737,075 741,037

^ Data as of December 31, 2017
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2015 Q1 - 2017 Q3
2015^ 2016^ 2017^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3
White 21,221 20,489 19,477 20,188 21,951 20,578 19,330 20,199 21,185 20,401 18,378
Black/African American 8,616 8,084 7,491 7,930 8,439 8,034 7,347 7,638 8,434 7,660 7,165
Native American/Alaska Native 306 289 271 265 307 324 290 285 322 288 257
Asian 1,299 1,238 1,153 1,219 1,413 1,287 1,207 1,279 1,427 1,335 1,222
Pacific Islander 357 368 374 369 417 404 393 357 392 387 332
Other/Unknown * * . * * * * * * * *
No ME Form 1,119 1,070 982 935 1,001 921 868 880 1,066 1,139 1,372
Hispanic 4,622 4,439 4,053 4,343 4,869 4,348 3,981 4,210 4,456 4,317 3,922
Non-Hispanic 27,176 26,029 24,713 25,631 27,658 26,280 24,585 25,547 27,304 25,754 23,432
Unknown * * . * * * * * * * *
No ME Form 1,119 1,070 982 935 1,001 921 868 880 1,066 1,139 1,372
Hemodialysis (%)1 90.76 89.73 89.09 90.11 90.34 89.79 89.16 90.26 90.3 89.2 88.8
CAPD (%)1 4.67 5.38 5.75 5.23 4.67 4.75 5.02 4.41 4.27 4.88 5.02
CCPD (%)1 4.54 4.88 5.14 4.65 4.99 5.44 5.8 5.31 5.42 5.91 6.17
Other (%)1 0.032 0.017 0.021 0.01 0.006 0.023 0.018 0.024 0.01 0.003 0.015
Unknown (%)1 . . . . . . . . . 0.003 .
Cathether Only (%)2 61.87 61.15 61.37 62.79 62.65 62.26 61.8 63.26 63 62.44 63
Catheter w/ maturing AVF (%)2 17.22 16.64 15.71 15.76 16.09 16.62 15.84 15.72 15.6 15.62 14.87
Catheter w/ maturing AVG (%)2 1.69 1.8 1.81 1.71 1.6 1.64 1.6 1.6 1.57 1.49 1.4
AVF (%)2 16.18 17.23 17.81 16.55 16.61 16.28 17.2 16.49 16.6 17.11 17.4
AVG (%)2 2.8 3 3.11 3 2.86 3.06 3.36 2.81 3.06 3.16 3.08
Other(%)2 0.2 0.16 0.14 0.14 0.15 0.085 0.18 0.12 0.13 0.14 0.17
Unknown(%)2 0.032 0.022 0.04 0.045 0.042 0.052 0.016 0.004 0.028 0.03 0.088
Pre-ESRD EPO(% Yes)3 13.47 13.58 13.68 13.21 13.25 13.12 13.16 13.26 12.96 13.82 13.68
Pre-ESRD Nephrology(% Yes)3 72.71 73.95 74.54 73.94 74.52 75.49 76.24 75.8 76.33 77.98 78.64
Mean Serum Albumin(g/dL)4 3.16 3.21 3.23 3.19 3.16 3.2 3.22 3.18 3.17 3.22 3.24
Mean Serum Creatinine(mg/dL)4 6.57 6.49 6.48 6.47 6.45 6.43 6.45 6.45 6.43 6.42 6.42
Mean Hemoglobin(g/dL)4 9.4 9.44 9.44 9.35 9.34 9.37 9.39 9.31 9.31 9.36 9.4
All 32,921 31,541 29,748 30,911 33,530 31,551 29,436 30,640 32,827 31,212 28,727
All with ME Form 31,802 30,471 28,766 29,976 32,529 30,630 28,568 29,760 31,761 30,073 27,355
Dialysis Pts with ME Form 31,234 29,836 28,107 29,370 31,975 30,009 27,968 29,171 31,203 29,504 26,774
Hemodialysis Pts w/ ME Form 28,349 26,772 25,040 26,464 28,885 26,945 24,937 26,329 28,177 26,318 23,775

^ Data as of December 31, 2017.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.